Development and validation of RP-HPLC method for simultaneous determination of lamivudine, stavudine, and zidovudine in perfusate samples
Application to the Single-Pass Intestinal Perfusion (SPIP) studies
DOI:
https://doi.org/10.1590/s2175-97902020000419073Keywords:
Antiretroviral drugs. Chromatographic method. RP-HPLC. Permeability. SPIPAbstract
A reversed-phase high performance liquid chromatography (RP-HPLC) method with ultraviolet detection was developed and validated for the simultaneous quantification of antiretroviral drugs lamivudine (3TC), stavudine (d4T), and zidovudine (AZT) in perfusate samples obtained from the Single-Pass Intestinal Perfusion studies. The chromatographic analysis was performed using a Gemini C18 column and didanosine as internal standard (IS). The following parameters were considered for the validation procedure: system suitability, accuracy, precision, linearity and selectivity. The limits of detection were 0.32 µg/mL for 3TC, 0.11 µg/mL for d4T and 0.45 µg/mL for AZT and the limits of quantification were 1.06 µg/mL for 3TC, 0.38 µg/mL for d4T and 1.51 µg/mL for AZT. Repeatability and intermediate precision ranged from 1.05 to 1.31 and 1.50 to 1.87, respectively, and are expressed as percent of relative standard deviation (RSD). Based on these results, the developed and validated RP-HPLC method can be used for simultaneous determination of 3TC, d4T, and AZT in perfusate samples. Furthermore, this method is simple and adequate for measurements of the antiretroviral drugs in the same sample, since those compounds are mostly co-administered. Besides, this work can be used as an initial base for the development of similar methods in the same conditions presented in our study.
Downloads
References
Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413-20.
Aymard G, Legrand M, Trichereau N, Diquet B. Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 2000;744(2):227-40.
Balimane PV, Chong S, Morrison RA. Current methodologies used for evaluation of intestinal permeability and absorption. J Pharmacol Toxicol Methods. 2000;44(1):301-12.
Balimane PV, Sinko PJ. Involvement of multiple transporters in the oral absorption of nucleoside analogues. Adv Drug Deliv Rev. 1999;39(1-3):183-209.
CDER/FDA. Guidance for Industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. Center for Drug Evaluation and Research, 2017. Available from: Available from: https://www.fda.gov/downloads/Drugs/Guidances/ucm070246.pdf Accessed on: 19 January 2019.
» https://www.fda.gov/downloads/Drugs/Guidances/ucm070246.pdf
Dahan A, West BT, Amidon GL. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat. Eur J Pharm Sci. 2009;36(2-3):320-9.
Dezani AB, Pereira TM, Caffaro AM, Reis JM, Serra CHR. Determination of lamivudine and zidovudine permeability using a different ex vivo method in Franz cells. J Pharmacol Toxicol Methods . 2013;67(3):194-202.
Dezani TM, Dezani AB, Silva MMC, Serra CHR. In situ intestinal perfusion in rodents: Future perspectives for application on absorption studies and classification of drugs. Mini Rev Med Chem. 2017;17(9):746-57.
Dezani TM, Dezani AB, Junior JBS, Serra CHR. Single-Pass Intestinal Perfusion (SPIP) and prediction of fraction absorbed and permeability in humans: A study with antiretroviral drugs. Eur J Pharm Biopharm. 2016;104:131-9.
Fan B, Stewart JT. Determinations of zidovudine/didanosine/nevirapine and zidovudine/didanosine/ritonavir in human serum by micellar electrokinetic chromatography. J Pharm Biomed Anal. 2002;30(4):955-60.
Food and Drug Administration, 2019a. Antiretroviral drugs used in the treatment of HIV infection. Available from: Available from: https://www.fda.gov/ForPatients/Illness/HIVAIDS/Treatment/ucm118915.htm Accessed on: 19 January 2019.
» https://www.fda.gov/ForPatients/Illness/HIVAIDS/Treatment/ucm118915.htm
Food and Drug Administration, 2019b. Drugs@FDA: FDA Approved Drug Products. Available from: Available from: https://www.accessdata.fda.gov/scripts/cder/daf/ Accessed on: 19 January 2019.
» https://www.accessdata.fda.gov/scripts/cder/daf/
Huang Y, Zurlinden E, Lin E, Li X, Tokumoto J, Golden J, et al. Liquid chromatographic-tandem mass spectrometric assay for the simultaneous determination of didanosine and stavudine in human plasma, bronchoalveolar lavage fluid, alveolar cells, peripheral blood mononuclear cells, seminal plasma, cerebrospinal fluid and tonsil tissue. J Chromatogr B Biomed Sci Appl . 2004;799(1):51-61.
International Conference on Harmonisation. ICH harmonized tripartite guideline, Validation of analytical procedures: text and methodology Q2 (R1), 2005. 13p. Available from: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf Accessed on: 19 January 2019.
Jain R, Duvvuri S, Kansara V, Mandava NK, Mitra AK. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats. Int J Pharm. 2007;336(2):233-40.
Kano EK, Serra CHR, Koono EEM, Andrade SS, Porta V. Determination of lamivudine in human plasma by HPLC and its use in bioequivalence studies. Int J Pharm . 2005;297(1-2):73-9.
Kaul S, Stouffer B, Mummaneni V, Turabi N, Mantha S, Jayatilak P, et al. Specific radioimmunoassays for the measurement of stavudine in human plasma and urine. J Pharm Biomed Anal . 1996;15(2):165-74.
Kenney KB, Wring SA, Carr RM, Wells GN, Dunn JA. Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry. J Pharm Biomed Anal . 2000;22(6):967-83.
Kim JS, Mitchell S, Kijek P, Tsume Y, Hilfinger J, Amidon GL. The suitability of an in situ perfusion model for permeability determinations: Utility for BCS class I biowaiver requests. Mol Pharm. 2006;3(6):686-94.
Kumar VR, Reddy BPB, Kumar BR, Sreekanth K, Babu KN. High Throughput LC-MS/MS method for simultaneous determination of zidovudine, lamivudine and nevirapine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;921-922:9-14.
Lennernäs H. Human intestinal permeability. J Pharm Sci. 1998;87(4):403-10.
Lennernäs H, Nylander S, Ungell AL. Jejunal permeability: A comparison between the Ussing chamber technique and the Single-Pass perfusion in humans. Pharm Res . 1997;14(5):667-71.
Moyer TP, Temesgen Z, Enger R, Estes L, Charlson J, Oliver L, et al. Drug monitoring of antiretroviral therapy for HIV-1 infection: method validation and results of a pilot study. Drug Monit Toxicol. 1999;45(9):1465-76.
Mukherjee A, Bera A. A detailed study of validation parameters and system suitability test in HPLC. Res J Pharm Biol Chem Sci. 2012;3(4):426-47.
Patil SR, Kumar L, Kohli G, Bansal AK. Validated HPLC method for concurrent determination of antipyrine, carbamazepine, furosemide and phenytoin and its application in assessment of drug permeability through Caco-2 cell monolayers. Sci Pharm. 2012;80(1):89-100.
Porta V, Schramm SG, Kano EK, Koono EE, Armando YP, Fukuda K, et al. HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studies. J Pharm Biomed Anal . 2008;46(1): 143-7.
Reis JM, Dezani AB, Pereira TM, Avdeef A, Serra CHR. Lamivudine permeability study: A comparison between PAMPA, ex vivo and in situ Single-Pass Intestinal Perfusion (SPIP) in rat jejunum. Eur J Pharm Sci . 2013;48(4-5):781-9.
Russo G, Barbato F, Grumetto L. A validated LC/UV method for the determination of four adulterating drugs in herbal slimming capsules. J Pharm Biomed Anal . 2016;117:436-45.
Sarasa M, Riba N, Zamora L, Carné X. Determination of stavudine in human plasma and urine by high-performance liquid chromatography using a reduced sample volume. J Chromatogr B Biomed Sci Appl . 2000;746(2):183-9.
Strauch S, Jantratid E, Dressman JB, Junginger HE, Kopp S, Midha KK, et al. Biowaiver monographs for immediate release solid oral dosage forms: Lamivudine. J Pharm Sci. 2011;100(6):2054-63.
Verweij-Van Wissen CPWGM, Aarnoutse RE, Burger DM. Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;816(1-2):121-9.
Zakeri-Milani P, Barzegar-Jalali M, Tajerzadeh H, Azarmi Y, Valizadeh H. Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation. J Pharm Biomed Anal . 2005; 39(3-4):624-30
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
